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Abstract
Genome-wide association studies are very powerful in determining the genetic variants affecting complex diseases.
Most of the available methods are very useful in detecting association between common variants and complex
diseases. Recently, methods to detect rare variants in association with complex diseases have been developed with
the increasingly available sequencing data from next-generation sequencing. In this paper, we evaluate and
compare several of these recent methods for performing statistical association using whole genome sequencing
data in pedigrees. Specifically, functional principalcomponent analysis (FPCA), extended combined multivariate and
collapsing (CMC) method for families, a generalized T2 method, and chi-square minimum approach were
compared by analyzing all the genetic variants, common and rare, of both the real data set and the simulated data
set provided as part of Genetic Analysis Workshop 18.
Background
With advances in genotyping technologies, genome-wide
association studies (GWAS) became a very popular procedure to identify disease genes and other traits by conducting statistical tests on many thousands of singlenucleotide polymorphisms (SNPs). The procedure has
great potential for discovering genetic variants influencing complex diseases. However, these procedures have
discovered loci that account only for a small percentage
of phenotypic variance [1]. One of the reasons for this
difficulty may be that rare variants might explain disease
susceptibility [2-4]. Recently, several methods have been
developed to determine the influence of rare variants on
complex diseases. These methods differ from the traditional methods of testing where the focus has been on
individual common variants. It is understood that those
variants with a population frequency greater than 5% are
considered to be common variants, those with less than
1% population frequency as rare variants, and the rest as
low-frequency variants [4]. The common variants are
believed to be from distant ancestors, whereas rare
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variants are from recent ancestors [5]. Most of these
methods assume the individuals are independent and are
designed for population-based data. Only recently have
several methods been developed that can perform statistical association of sequence data in pedigrees. In this
paper, we used functional principal component analysis
(FPCA) [4], the generalized T2 approach [4], the combined multivariate and collapsing (CMC) test for family
data [2,4], and the chi-square minimum approach for
family data [4] to analyze association of the dichotomous
hypertension trait with all genetic variants, common and
rare, of the real data set and all replicates of chromosome
3 of the simulated data set provided by Genetic Analysis
Workshop 18 (GAW 18) [6]. We compared the results to
assess the merits of these methods.

Methods
An extension of the generalized T2 test [7] for familybased association studies is provided by Zhu and Xiong
T2
, where T2 is
Pcorr
the generalized T2 statistic [7], and Pcorr [4, p. 1030] is
the correction factor to account for the familial correlation in the pedigree data. A similar extension of the
CMC test is also developed and is provided by equation

[4]. The test statistic is given by TF2 =

© 2014 Mathew et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Mathew et al. BMC Proceedings 2014, 8(Suppl 1):S48
http://www.biomedcentral.com/1753-6561/8/S1/S48

Page 2 of 4

(15) in Zhu and Xiong [4]. The test statistic is given by
TCMC
TCMCF =
, where TCMC is the CMC statistic for the
Pcorr
population-based association test, and Pcorr is the correction factor to adjust TCMC statistic so that it is valid for
pedigree data. The FPCA statistic for the populationbased association test in Luo et al [8] also has a similar
extension for family data [4], and is given by
TFPCA
TFPCAF =
, where TFPCA and Pcorr are defined as in
pcorr
the previous test statistics for pedigree data. Also, TF2,
T CMCF , and T FPCAF have chi-square distributions [4].
The chi-square minimum statistic chooses the minimum
of the p-values from the individual chi-square tests for
each genetic variant from a genomic region. The chisquare minimum statistic (Chi_min) adjusts for relatedness of pedigree members using Pcorr [4].
We applied the above 4 methods to analyze the real
data set from all odd-numbered chromosomes using
hypertension status at exam 1 as the phenotype. The
genotypes at each variant are coded as 0, 1, or 2 for aa,
Aa, and AA, where allele A is the minor allele. The start
and end boundary of all the human genes were obtained
from hg19 genome assembly at NCBI. The genetic variants within 1 gene were analyzed together as each gene
is 1 natural functional unit. For the FPCA method, if
there are too few genetic variants, that is, less than 3,
the estimate of the functional relation of the allele
counts across the genetic variants will be far off. Consequently, genes with fewer than 3 genetic variants were
not analyzed. The significant genes from the 4 methods
were then compared with the findings from previous
GWAS for genes associated with blood pressure.
To examine the type I error rate and power of the
4methods, we applied these methods to the 200 replicates
of the simulated data set and analyzed the data from
chromosome 3. As in the real data analysis, we chose the
hypertension status at exam 1 as the phenotype.

Results
Table 1 gives the number of significant genes at several
a levels from the real data analysis for a total of 10,580
genes from the odd-numbered human chromosomes.
Table 1 Number of significant genes out of 10,580 genes
in the odd-numbered human chromosomes of the real
data set at various significance levels
Method

Significance level
0.05

0.01

0.001

0.0001

4.7 × 10−6

FPCA

158

33

3

1

0

Chi_min

8321

5123

1402

172

15

T2

3902

3079

2436

2050

1794

CMC

2083

1329

907

717

598

FPCA method finds the fewest number of significant
genes compared to the other 3 methods. Chi_min finds
the highest number of significant genes at 0.05 and 0.01
levels. However, T 2 finds more significant genes at
lower significance levels (0.001, 0.0001, and 4.7 × 10−6).
The number of genessignificant at the 4.7 × 10−6 level
by the FPCA, Chi_min, CMC, and T 2 methods are 0,
15, 598, and 1794, respectively. Figure 1 is a Venn diagram showing overlaps of the significant genes from
Chi_min, CMC, and T2 at 4.7 × 10−6 level. It is interesting to note that all 598 significant genes found by CMC
overlap with those found by T2.
The number of significant genes presented in Table 1
will contain false positives, as with any statistical test.
To get an idea of the number of “true findings,” we
compared our results with those findings of GWAS for
blood-pressure-associated genes. We performed a comprehensive literature review, and 84 genes were identified as being associated with blood pressure from
GWAS. Table 2 shows the number of overlapped genes
between our analysis and the GWAS findings.
We analyzed chromosome 3 of the simulated data set.
There are a total of 1120 genes on chromosome 3, of
which 30 were used for causal variants of hypertension
in the simulation model. The remaining 1090 were
assumed to be unrelated to the disease and are used
only for calculating type I error rate. The linkage disequilibrium (LD) between the genetic variants from these
groups of 1090 genes and 30 genes were analyzed with
Haploview [9] and no significant LD was found. Table 3
lists the type I error rates from the analysis of all 200
replicates by all 4 methods at various significance levels.
The analysis of the 30 positive genes is used to calculate the power of the various methods. Table 4 lists the
estimates of the power by the various methods.

Discussion
With the increasingly available sequence data from the
next-generation sequencing technologies, it is important
for a statistical association method to handle both common
and rare genetic variants. It is also important for these
methods to handle data from pedigrees because rare
genetic variants are enriched in families with multiple
affected individuals, which could confer more statistical
power. From our analysis of the real data, T2 seems to be a
better method than the other 3 methods because it finds
more significant genes at low significance levels. At the
Bonferroni corrected p-value of 4.7 × 10−6 , T2 identified
the genes CASZ1, ADAMTS8, NUCB2, ABCC8, SLC4A7,
MAP4, CASR, EBF1, PLEKHA7, SOX6, ULK4, and
MECOM. The last 4 genes were also identified by the CMC
method. All the genes mentioned above were found to be
associated with blood pressure, in particular ULK4 and
PLEKAH7 by Levy et al [10], and MAP4 by Wain et al [11].
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Figure 1 Venn diagram showing overlaps of the significant genes from Chi_min, CMC, and T2 at 4.7 × 10−6 level from the analysis all
odd-numbered chromosomes of the real data set.

Table 2 Number of overlapped genes associated with
blood pressure from GWAS findings at various
significance levels
Method

0.05

0.01

0.001

0.0001

4.7 × 10−6

FPCA
Chi_min

0
36

0
23

0
9

0
1

0
0

T2

20

18

14

12

12

CMC

12

10

7

5

4

Table 3 Type I error probability estimates by FPCA,
Chi_min, T2, and CMC methods from all 200 replicates of
chromosome 3 of the simulated data set
a
0.05
0.01

FPCA

Chi_min

T2

CMC

0.02567
0.00656

0.86265
0.61023

0.05061
0.01202

0.04763
0.00908

0.001

0.00096

0.25719

0.00093

0.00136

0.0001

0.00016

0.07272

0.00013

0.00011

Table 4 Estimates of power by FPCA, Chi_min, T2, and
CMC methods from all 200 replicates of chromosome 3
of thesimulated data set
a

FPCA

Chi_min

T2

CMC

0.05
0.01

0.045
0.01883

0.95433
0.72117

0.6585
0.57717

0.338
0.24583

0.001

0.00483

0.33233

0.50117

0.18083

0.0001

0.00117

0.09667

0.448

0.14233

As with GWAS, we need to keep a low significance
level to account for multiple testing. We note from the
analysis of the simulated data that FPCA has empirical

type I error rate much less than the nominal value,
making it very conservative. The Chi_min method has
inflated type I error rate. The type I error rates by T2
and CMC are close to the nominal value. Also, T2 has
better power than CMC, which is consistent with the
result from the real data.
From the analysis of the data sets we find that T2 is a
better method, which is different from the findings of
Zhu and Xiong [4], which suggest that FPCA is a better
procedure. There are 2 possible reasons why FPCA performs less well here. One reason may be that the SNPs in
the genes are sparse. If there are too few SNPs in 1 gene,
the FPCA may not perform well because the number of
SNPs is not enough to estimate the function describing
the allele counts across the SNPs in the gene. A second
reason may be that the assumption of a smooth function
of the allele counts across the SNPs for the FPCA may
not hold for the GAW 18data sets. We observed a large
overlap between the results of CMC and T2. This mainly
comes from the fact that CMC uses the T 2 approach
with common variants. There is also a tendency to pick
up more genes with more variants for both CMC and T2
methods.

Conclusions
From the analysis results of both real and simulated
data, T2 is a preferable method for pedigree-based association studies with whole-genome sequencing data
because it controls the false positive rate and is more
powerful than the other two methods with similar type I
error rates.
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